BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30475303)

  • 1. Oral Methods of Urinary Alkalinization for High-dose Methotrexate Administration: Alternatives to Intravenous Sodium Bicarbonate During a Critical Drug Shortage.
    Visage R; Kaiser N; Williams M; Kim A
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):371-375. PubMed ID: 30475303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate.
    Rouch JA; Burton B; Dabb A; Brown V; Seung AH; Kinsman K; Holdhoff M
    J Oncol Pharm Pract; 2017 Jan; 23(1):3-9. PubMed ID: 26467268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage.
    Roy AM; Lei M; Lou U
    J Oncol Pharm Pract; 2019 Dec; 25(8):1860-1866. PubMed ID: 30636529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization.
    Heisler RD; Kelly JJ; Abedinzadegan Abdi S; Hawker JL; Fong LG; Quon JL; Rioux JZ; Jupp JC
    Support Care Cancer; 2022 Feb; 30(2):1273-1281. PubMed ID: 34471970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience.
    Diachinsky M; Tran T; Jupp J; McKinnon K
    J Oncol Pharm Pract; 2021 Jan; 27(1):119-127. PubMed ID: 32316877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of sodium acetate use for urine alkalinization in patients receiving high dose methotrexate.
    Perkey CL; Flynn LA; Lentz K; Butler S
    J Oncol Pharm Pract; 2023 Jan; 29(1):119-124. PubMed ID: 34931924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
    Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
    Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate.
    Clemmons AB; Chase A; Duong P; Waller JL; Saunders K; Bryan L
    Support Care Cancer; 2021 Mar; 29(3):1527-1534. PubMed ID: 32725375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis.
    Kaveh-Ahangaran R; Abdollahi M; Vaezi M; Kasaeian A; Bahlouli Z; Janbabaei G; Mojtahedzadeh A; Mojtahedzadeh M; Djalalinia S; Shahrami B
    Daru; 2024 Jun; 32(1):353-377. PubMed ID: 38233724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage.
    Mangum R; Bernhardt MB; Cheng WS; Schafer ES; Berg SL; Foster JH
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28334. PubMed ID: 32608575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate.
    Kintzel PE; Campbell AD; Yost KJ; Brinker BT; Arradaza NV; Frobish D; Wehr AM; O'Rourke TJ
    J Oncol Pharm Pract; 2012 Jun; 18(2):239-44. PubMed ID: 22075004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory High-dose Methotrexate Administration in Pediatric Osteosarcoma Patients at a Single Institution in Argentina.
    Villegas Rubio JA; Cacciavillano W; Rose A; Zubizarreta P; Scopinaro M
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):e349-e352. PubMed ID: 28937522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of urine alkalinization by oral administration of sodium bicarbonate: a prospective open-label trial.
    Cohen B; Laish I; Brosh-Nissimov T; Hoffman A; Katz LH; Braunstein R; Sagi R; Michael G
    Am J Emerg Med; 2013 Dec; 31(12):1703-6. PubMed ID: 24055481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of sodium acetate for sodium bicarbonate for urine alkalinization in high-dose methotrexate therapy.
    Alrabiah Z; Luter D; Proctor A; Bates JS
    Am J Health Syst Pharm; 2015 Nov; 72(22):1932-4. PubMed ID: 26541946
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate.
    Reed DR; Pierce EJ; Sen JM; Keng MK
    Cancer Manag Res; 2019; 11():8065-8072. PubMed ID: 31507329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate.
    Kramer E; Filtz M; Pace M
    J Oncol Pharm Pract; 2021 Jan; 27(1):26-32. PubMed ID: 32164493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Sodium Bicarbonate and Lactated Ringers Hydration for High-dose Methotrexate Chemotherapy in Children.
    Kendrick J; Jacques L; Baadjes B; Carr R
    J Pediatr Hematol Oncol; 2022 Nov; 44(8):442-445. PubMed ID: 36301046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
    Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with ambulatory high-dose methotrexate administration as CNS prophylaxis in patients with non-Hodgkin lymphoma.
    Pampín R; Labeaga Y; Rodríguez B; Fernández B; Fernández R; Carbajales M
    J Oncol Pharm Pract; 2020 Apr; 26(3):549-555. PubMed ID: 31156052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
    Mir O; Ropert S; Babinet A; Alexandre J; Larousserie F; Durand JP; Enkaoua E; Anract P; Goldwasser F
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1059-63. PubMed ID: 20155268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.